CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Revenue

CRISPR Therapeutics AG had revenue of $271.71M in the twelve months ending March 31, 2024, with 171.01% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $504.00K, a -99.50% decrease year-over-year. In the year 2023, CRISPR Therapeutics AG had annual revenue of $371.21M with 30,885.48% growth.

• Revenue (ttm): $271.71M
• Revenue Growth: +171.01%
• P/S Ratio: 16.60
• Revenue / Employee: $667,592
• Employees: 407
• Market Cap: 4.51B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	371.21M	370.01M	30,885.48%
Dec 31, 2022	1.20M	-913.77M	-99.87%
Dec 31, 2021	914.96M	914.24M	127,154.94%
Dec 31, 2020	719.00K	-288.87M	-99.75%
Dec 31, 2019	289.59M	286.47M	9,169.85%
Dec 31, 2018	3.12M	-37.87M	-92.38%
Dec 31, 2017	41.00M	35.83M	693.90%
Dec 31, 2016	5.16M	4.92M	1,990.69%
Dec 31, 2015	247.00K	-	-
Dec 31, 2014	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.